Industry News
The Magnitude Of Variation In Gene Expression Measurements Within Breast Cancers Revealed By Study
May 06, 2013
An important new study has revealed the clearest picture yet of precisely how much measurement variation influences gene expression profiles of breast cancer. The results show, for the first time, which gene expression measurements may benefit from pooling of biopsies from a single tumour, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium... Read More
In Estrogen Receptor POS Breast Cancer, Genetic And Clinical Factors Best To Predict Late Recurrence
May 06, 2013
A new analysis has provided a comprehensive comparison of scores designed to predict which women with oestrogen-receptor positive breast cancer are at high risk of recurrence beyond five years after diagnosis, and may benefit from prolonged endocrine treatment... Read More
Dissimilar Proteins Evolved Similar 7-Part Shape: Findings Offer Insight Into A Molecule Involved In Cancer And Birth Defects
May 05, 2013
Solving the structure of a critical human molecule involved in cancer, scientists at The Scripps Research Institute (TSRI) have found what they call a good example of structural conservation - dissimilar genes that keep very similar shapes... Read More
Cancer Patients Moving To England To Access Treatments
May 04, 2013
Clinicians considering the same and have concerns for the future of cancer care in Scotland New research from a survey of oncologists and haematologists in Scotland* has revealed that over a third (39%) are aware of cancer patients who have relocated to England to receive treatment... Read More
Deaths From Prostate Cancer Lower Among Statin Users
May 04, 2013
New research from the US suggests men with prostate cancer who took or started taking statins before their diagnosis, may reduce their risk of dying from the disease. Statins are a class of drugs prescribed for lowering cholesterol. Lead researcher Janet L. Stanford, of Fred Hutchinson Cancer Research Center (FHCRC) in Seattle, Washington, and colleagues... Read More
Routine PSA Tests No Longer Recommended - American Urological Association
May 04, 2013
Members of the American Urological Association (AUA) recently got together and made a series of new recommendations concerning prostate cancer screening. They now discourage screening men who are at average-risk under the age 55. The AUA says that men should be particularly cautious before making the decision to go through with the screening and weigh the benefits against the potential harms... Read More
More Younger Women Getting Breast Cancer
May 04, 2013
The number of younger women (aged under 50) being diagnosed with breast cancer has topped 10,000 in one year for the first time in the United Kingdom, says Cancer Research UK, a charity. Today in the UK, out of every five women who are diagnosed with breast cancer, one is aged under 50 years. Each year nearly 50,000 breast cancer diagnoses are made... Read More
Octava Pink Test To Verify Negative Mammography Results And Detect Missed Breast Cancers Receives CE Mark Designation
May 04, 2013
Accurate, Rapid, Cost-Effective Blood Test Aims to Confirm True Negative Findings While Halving the Rate of False Negative Mammography Results Eventus Diagnostics, Inc. (EventusDx) have announced that it has received CE mark designation for its Octava PinkTM breast cancer test intended for confirmatory use in women who have received negative mammography results... Read More
A Blood Sample Predicts If Cancer Patients Respond To Therapy
May 04, 2013
Karolinska Institutet and University Hospital have shown that a simple blood test can predict breast cancer patients response to therapy, how long treatment will be effective and survival. The results are being presented at the IMPAKT scientific conference in Brussels, May 2-4... Read More
AUA Releases New Clinical Guideline On Prostate Cancer Screening
May 03, 2013
Men ages 55 to 69 urged to talk with their doctors about benefits, harms of testing Men ages 55 to 69 who are considering prostate cancer screening should talk with their doctors about the benefits and harms of testing and proceed based on their personal values and preferences, according to a new clinical practice guideline released today by the American Urological Association (AUA)... Read More
Previous Page Next Page